{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T10:23:20Z","timestamp":1776248600812,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100008710","name":"Dementia Australia Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00198-025-07676-x","type":"journal-article","created":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T02:13:35Z","timestamp":1765073615000},"page":"673-690","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The effectiveness of bisphosphonates vs denosumab in people with dementia or frailty post hip fracture: a multi-database cohort study"],"prefix":"10.1007","volume":"37","author":[{"given":"Jenni","family":"Ilom\u00e4ki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2526-729X","authenticated-orcid":false,"given":"George S. Q.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella Jung-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam T. Y.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chor-Wing","family":"Sing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Lung","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward Chia-Cheng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyuki Hsing-Chun","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-Tian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wallis C. Y.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian C. K.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian D.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Simon","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,7]]},"reference":[{"key":"7676_CR1","unstructured":"The Royal Australian College of General Practitioners (2024) Osteoporosis management and fracture prevention in postmenopausal women and men over 50 years of age. 3rd edn. RACGP, East Melbourne, Vic"},{"key":"7676_CR2","doi-asserted-by":"publisher","first-page":"818","DOI":"10.7326\/M15-1361","volume":"166","author":"A Qaseem","year":"2017","unstructured":"Qaseem A, Forciea MA, McLean RM et al (2017) Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the American College of Physicians. Ann Intern Med 166:818\u2013839","journal-title":"Ann Intern Med"},{"key":"7676_CR3","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1503\/cmaj.141331","volume":"187","author":"A Papaioannou","year":"2015","unstructured":"Papaioannou A, Santesso N, Morin SN et al (2015) Recommendations for preventing fracture in long-term care. Can Med Assoc J 187:1135","journal-title":"Can Med Assoc J"},{"key":"7676_CR4","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1007\/s00198-012-2250-0","volume":"24","author":"YK Lee","year":"2013","unstructured":"Lee YK, Ha YC, Yoon BH, Koo KH (2013) Incidence of second hip fracture and compliant use of bisphosphonate. Osteoporos Int 24:2099\u20132104","journal-title":"Osteoporos Int"},{"key":"7676_CR5","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1210\/jc.2018-02236","volume":"104","author":"H Lyu","year":"2019","unstructured":"Lyu H, Jundi B, Xu C, Tedeschi SK, Yoshida K, Zhao S, Nigwekar SU, Leder BZ, Solomon DH (2019) Comparison of denosumab and bisphosphonates in patients with osteoporosis: a meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 104:1753\u20131765","journal-title":"J Clin Endocrinol Metab"},{"key":"7676_CR6","doi-asserted-by":"publisher","first-page":"e192416","DOI":"10.1001\/jamanetworkopen.2019.2416","volume":"2","author":"AB Pedersen","year":"2019","unstructured":"Pedersen AB, Heide-J\u00f8rgensen U, S\u00f8rensen HT, Prieto-Alhambra D, Ehrenstein V (2019) Comparison of risk of osteoporotic fracture in denosumab vs alendronate treatment within 3 years of initiation. JAMA Netw Open 2:e192416\u2013e192416","journal-title":"JAMA Netw Open"},{"key":"7676_CR7","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.jamda.2010.12.001","volume":"12","author":"DP Seitz","year":"2011","unstructured":"Seitz DP, Adunuri N, Gill SS, Rochon PA (2011) Prevalence of dementia and cognitive impairment among older adults with hip fractures. J Am Med Dir Assoc 12:556\u2013564","journal-title":"J Am Med Dir Assoc"},{"key":"7676_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3138\/ptc.2016-14","volume":"69","author":"E Fernando","year":"2017","unstructured":"Fernando E, Fraser M, Hendriksen J, Kim CH, Muir-Hunter SW (2017) Risk factors associated with falls in older adults with dementia: a systematic review. Physiother Can 69:161\u2013170","journal-title":"Physiother Can"},{"key":"7676_CR9","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1177\/0269215514542358","volume":"29","author":"S Liu","year":"2015","unstructured":"Liu S, Zhu Y, Chen W, Sun T, Cheng J, Zhang Y (2015) Risk factors for the second contralateral hip fracture in elderly patients: a systematic review and meta-analysis. Clin Rehabil 29:285\u2013294","journal-title":"Clin Rehabil"},{"key":"7676_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/ageing\/afq146","volume":"40","author":"NL Baker","year":"2011","unstructured":"Baker NL, Cook MN, Arrighi HM, Bullock R (2011) Hip fracture risk and subsequent mortality among Alzheimer\u2019s disease patients in the United Kingdom, 1988\u20132007. Age Ageing 40:49\u201354","journal-title":"Age Ageing"},{"key":"7676_CR11","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jamda.2013.12.011","volume":"15","author":"DP Seitz","year":"2014","unstructured":"Seitz DP, Gill SS, Gruneir A, Austin PC, Anderson GM, Bell CM, Rochon PA (2014) Effects of dementia on postoperative outcomes of older adults with hip fractures: a population-based study. J Am Med Dir Assoc 15:334\u2013341","journal-title":"J Am Med Dir Assoc"},{"key":"7676_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.31128\/AJGP-04-18-4544","volume":"48","author":"N Mughal","year":"2019","unstructured":"Mughal N, Inderjeeth AJ, Inderjeeth CA (2019) Osteoporosis in patients with dementia is associated with high morbidity and mortality: findings from a single orthogeriatric unit. Aust J Gen Pract 48:53\u201358","journal-title":"Aust J Gen Pract"},{"key":"7676_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41584-024-01094-9","volume":"20","author":"NR Fuggle","year":"2024","unstructured":"Fuggle NR, Beaudart C, Bruy\u00e8re O et al (2024) Evidence-based guideline for the management of osteoporosis in men. Nat Rev Rheumatol 20:241\u2013251","journal-title":"Nat Rev Rheumatol"},{"issue":"Suppl 1","key":"7676_CR14","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.jfma.2023.01.007","volume":"122","author":"TW Tai","year":"2023","unstructured":"Tai TW, Huang CF, Huang HK et al (2023) Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: 2022 update. J Formos Med Assoc 122(Suppl 1):S4-s13","journal-title":"J Formos Med Assoc"},{"issue":"Suppl 2","key":"7676_CR15","first-page":"1","volume":"30","author":"TP Ip","year":"2024","unstructured":"Ip TP, Lee CA, Lui TD et al (2024) 2024 OSHK guideline for clinical management of postmenopausal osteoporosis in Hong Kong. Hong Kong Med J 30(Suppl 2):1\u201344","journal-title":"Hong Kong Med J"},{"key":"7676_CR16","doi-asserted-by":"publisher","first-page":"168","DOI":"10.14283\/jfa.2021.4","volume":"10","author":"Y Rolland","year":"2021","unstructured":"Rolland Y, Cesari M, Fielding RA, Reginster JY, Vellas B, Cruz-Jentoft AJ (2021) Osteoporosis in frail older adults: recommendations for research from the ICFSR task force 2020. J Frailty Aging 10:168\u2013175","journal-title":"J Frailty Aging"},{"key":"7676_CR17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/agm2.12080","volume":"2","author":"B Kirk","year":"2019","unstructured":"Kirk B, Saedi AA, Duque G (2019) Osteosarcopenia: a case of geroscience. Aging Med 2:147\u2013156","journal-title":"Aging Med"},{"key":"7676_CR18","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1007\/s00198-010-1444-6","volume":"22","author":"PN Sambrook","year":"2011","unstructured":"Sambrook PN, Cameron ID, Chen JS, March LM, Simpson JM, Cumming RG, Seibel MJ (2011) Oral bisphosphonates are associated with reduced mortality in frail older people: a prospective five-year study. Osteoporos Int 22:2551\u20132556","journal-title":"Osteoporos Int"},{"key":"7676_CR19","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00198-019-05228-8","volume":"31","author":"J Morley","year":"2020","unstructured":"Morley J, Moayyeri A, Ali L, Taylor A, Feudjo-Tepie M, Hamilton L, Bayly J (2020) Persistence and compliance with osteoporosis therapies among postmenopausal women in the UK clinical practice research datalink. Osteoporos Int 31:533\u2013545","journal-title":"Osteoporos Int"},{"key":"7676_CR20","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00198-016-3783-4","volume":"28","author":"TY Wu","year":"2017","unstructured":"Wu TY, Hu HY, Lin SY, Chie WC, Yang RS, Liaw CK (2017) Trends in hip fracture rates in Taiwan: a nationwide study from 1996 to 2010. Osteoporos Int 28:653\u2013665","journal-title":"Osteoporos Int"},{"key":"7676_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/YCO.0000000000000579","volume":"33","author":"J Ilomaki","year":"2020","unstructured":"Ilomaki J, Lai EC, Bell JS (2020) Using clinical registries, administrative data and electronic medical records to improve medication safety and effectiveness in dementia. Curr Opin Psychiatry 33:163\u2013169","journal-title":"Curr Opin Psychiatry"},{"key":"7676_CR22","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s40263-020-00742-4","volume":"34","author":"J Ilomaki","year":"2020","unstructured":"Ilomaki J, Bell JS, Chan AYL et al (2020) Application of healthcare \u2018Big Data\u2019 in CNS drug research: the example of the neurological and mental health Global Epidemiology Network (NeuroGEN). CNS Drugs 34:897\u2013913","journal-title":"CNS Drugs"},{"key":"7676_CR23","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2147\/CLEP.S196293","volume":"11","author":"CY Hsieh","year":"2019","unstructured":"Hsieh CY, Su CC, Shao SC, Sung SF, Lin SJ, Kao Yang YH, Lai EC (2019) Taiwan\u2019s national health insurance research database: past and future. Clin Epidemiol 11:349\u2013358","journal-title":"Clin Epidemiol"},{"key":"7676_CR24","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/pds.4208","volume":"26","author":"CW Sing","year":"2017","unstructured":"Sing CW, Woo YC, Lee ACH, Lam JKY, Chu JKP, Wong ICK, Cheung CL (2017) Validity of major osteoporotic fracture diagnosis codes in the clinical data analysis and reporting system in Hong Kong. Pharmacoepidemiol Drug Saf 26:973\u2013976","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"7676_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12916-021-01900-1","volume":"19","author":"TT Ma","year":"2021","unstructured":"Ma TT, Wong ICK, Whittlesea C, Man KKC, Lau W, Wang Z, Brauer R, MacDonald TM, Mackenzie IS, Wei L (2021) Impact of multiple cardiovascular medications on mortality after an incidence of ischemic stroke or transient ischemic attack. BMC Med 19:24","journal-title":"BMC Med"},{"key":"7676_CR26","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/S0140-6736(18)30668-8","volume":"391","author":"T Gilbert","year":"2018","unstructured":"Gilbert T, Neuburger J, Kraindler J et al (2018) Development and validation of a hospital frailty risk score focusing on older people in acute care settings using electronic hospital records: an observational study. Lancet 391:1775\u20131782","journal-title":"Lancet"},{"key":"7676_CR27","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC (2011) An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 46:399\u2013424","journal-title":"Multivariate Behav Res"},{"key":"7676_CR28","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1210\/jc.2013-4175","volume":"99","author":"T Nakamura","year":"2014","unstructured":"Nakamura T, Matsumoto T, Sugimoto T et al (2014) Clinical trials express: fracture risk reduction with denosumab in Japanese postmenopausal women and men with osteoporosis: denosumab fracture intervention randomized placebo controlled trial (DIRECT). J Clin Endocrinol Metab 99:2599\u20132607","journal-title":"J Clin Endocrinol Metab"},{"key":"7676_CR29","unstructured":"Hong Kong Hospital Authority (2021) Hospital Authority Drug Formulary (HAD) Supplementary Operation Guideline version 16.3."},{"key":"7676_CR30","unstructured":"National Institute for Health and Care Excellence (2010) Denosumab for the prevention of osteoporotic fractures in postmenopausal women. Technology appraisal guidance [TA204]. National Institute for Health and Care Excellence, London"},{"key":"7676_CR31","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.4065\/83.9.1032","volume":"83","author":"MT Drake","year":"2008","unstructured":"Drake MT, Clarke BL, Khosla S (2008) Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc 83:1032\u20131045","journal-title":"Mayo Clin Proc"},{"key":"7676_CR32","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1186\/s12891-023-06865-1","volume":"24","author":"S Bishop","year":"2023","unstructured":"Bishop S, Narayanasamy MJ, Paskins Z, Corp N, Bastounis A, Griffin J, Gittoes N, Leonardi-Bee J, Langley T, Sahota O (2023) Clinicians\u2019 views of prescribing oral and intravenous bisphosphonates for osteoporosis: a qualitative study. BMC Musculoskelet Disord 24:770","journal-title":"BMC Musculoskelet Disord"},{"key":"7676_CR33","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1002\/jbmr.4627","volume":"37","author":"TW Tai","year":"2022","unstructured":"Tai TW, Hwang JS, Li CC, Hsu JC, Chang CW, Wu CH (2022) The impact of various anti-osteoporosis drugs on all-cause mortality after hip fractures: a nationwide population study. J Bone Miner Res 37:1520\u20131526","journal-title":"J Bone Miner Res"},{"key":"7676_CR34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11657-022-01125-6","volume":"17","author":"S-Y Lin","year":"2022","unstructured":"Lin S-Y, Chen Y-M, Chen W-J, Li C-Y, Ku C-K, Chen C-H, Chien L-N (2022) Treatment patterns of long-dose-interval medication for persistent management of osteoporosis in Taiwan. Arch Osteoporos 17:94","journal-title":"Arch Osteoporos"},{"key":"7676_CR35","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1093\/aje\/kwv214","volume":"182","author":"MA Brookhart","year":"2015","unstructured":"Brookhart MA (2015) Counterpoint: the treatment decision design. Am J Epidemiol 182:840\u2013845","journal-title":"Am J Epidemiol"},{"key":"7676_CR36","first-page":"38","volume":"47","author":"LT Thuy Trinh","year":"2018","unstructured":"Thuy Trinh LT, Achat H, Loh SM, Pascoe R, Assareh H, Stubbs J, Guevarra V (2018) Validity of routinely collected data in identifying hip fractures at a major tertiary hospital in Australia. Health Inf Manag 47:38\u201345","journal-title":"Health Inf Manag"},{"key":"7676_CR37","doi-asserted-by":"publisher","first-page":"k1315","DOI":"10.1136\/bmj.k1315","volume":"361","author":"K Richardson","year":"2018","unstructured":"Richardson K, Fox C, Maidment I et al (2018) Anticholinergic drugs and risk of dementia: case-control study. BMJ 361:k1315","journal-title":"BMJ"},{"key":"7676_CR38","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1016\/S2468-2667(17)30031-2","volume":"2","author":"K Donegan","year":"2017","unstructured":"Donegan K, Fox N, Black N, Livingston G, Banerjee S, Burns A (2017) Trends in diagnosis and treatment for people with dementia in the UK from 2005 to 2015: a longitudinal retrospective cohort study. Lancet Public Health 2:e149\u2013e156","journal-title":"Lancet Public Health"},{"key":"7676_CR39","first-page":"9","volume":"1","author":"MX Ji","year":"2015","unstructured":"Ji MX, Yu Q (2015) Primary osteoporosis in postmenopausal women. Chronic Dis Transl Med 1:9\u201313","journal-title":"Chronic Dis Transl Med"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-025-07676-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-025-07676-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-025-07676-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T09:37:04Z","timestamp":1776245824000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-025-07676-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,7]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["7676"],"URL":"https:\/\/doi.org\/10.1007\/s00198-025-07676-x","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,7]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JI reports grants from AstraZeneca, Amgen, National Health and Medical Research Council, and National Breast Cancer Foundation, outside the submitted work. CLC received honorarium and research grants from Amgen Inc to conduct \u201cBone-Targeted Agents (BTAs) Awareness Campaign for Prostate Cancer Patients with Bone Metastasis\u201d and \u201cValidation of the osteoporosis prediction algorithm for Chinese using logistic regression and advanced machine learning approach.\u201d WCYL received research funding outside the submitted work from AIR@InnoHK administered by Innovation and Technology Commission. ICKW received research grants from Amgen Inc to conduct study on \u201cGlobal Epidemiology of\u00a0Hip\u00a0Fracture\u201d and \u201cBone-Targeting Agents Among Asian Patients with Bone Metastases from Solid Tumors.\u201d JSB is supported by a National Health and Medical Research Council (NHMRC) Boosting Dementia Research Leadership Fellowship and has received grant funding or consulting funds from the NHMRC, Victorian Government Department of Health and Human Services, Dementia Australia Research Foundation, Yulgilbar Foundation, Aged Care Quality and Safety Commission, Dementia Centre for Research Collaboration, Pharmaceutical Society of Australia, Society of Hospital Pharmacists of Australia, GlaxoSmithKline Supported Studies Programme, Amgen, and several aged care provider organizations unrelated to this work. All grants and consulting funds were paid to the employing institution. SW, GSQT, SJHK, MTYL, CWS, ECCL, MHCH, TTM, and IDC declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}